6
I. Yavari et al. / Chinese Chemical Letters 23 (2012) 5–8
reduced pressure, and the residue was purified by flash column chromatography (SiO2; hexane/AcOEt 4:1) to afford
the pure title compounds. Compound 12a is known [12].
Dimethyl 2-(2-thioxobenzo[d]oxazol-3(2H)-yl) f umarate (3a): Yellow powder, yield: 0.27 g (92%), mp: 130–
132 8C. IR (KBr): 1731 (C O), 1729 (C O) cmÀ1. 1H NMR (CDCl3): d 3.64 (s, 3 H, MeO), 3.85 (s, 3 H, MeO), 6.83–
6.86(m, 1H, CH), 7.25–7.27(m, 2H, 2CH), 7.33(s,1H, CH), 7.37–7.39(m, 1H, CH). 13CNMR(CDCl3):d52.7(MeO),
53.6 (MeO), 109.8 (CH), 110.7 (CH), 124.6 (CH), 125.0(CH), 130.1(CH), 131.9 (C), 133.8(C), 147.9(C), 161.3 (C O),
162.2 (C O), 179.6 (C S). MS (EI, 70 eV): m/z (%) 293 (M+, 10), 262 (8), 235 (100), 207 (60), 163 (5), 150 (6), 76 (10).
Anal. Calcd. for C13H11NO5S (293.29): C, 53.24%; H, 3.78%; N, 4.78%. Found: C, 53.23%; H, 3.75%; N, 4.80%.
Diethyl 2-(2-thioxobenzo[d]oxazol-3(2H)-yl) f umarate (3b): Yellow powder, yield: 0.28 g (86%), mp: 110–
112 8C. IR (KBr): 1732 (C O), 1729 (C O) cmÀ1. 1H NMR (CDCl3): d 1.03 (t, 3 H, Me), 1.30 (t, 3 H, Me), 4.07 (m,
2H, OCH2), 4.30–4.37 (m, 2 H, OCH2), 6.84–6.87 (m, 1 H, CH), 7.23–7.26 (m, 2 H, 2 CH), 7.36 (s, 1 H, CH), 7.37–
7.39 (m, 1 H, CH). 13C NMR (CDCl3): d 13.6 (Me), 14.0 (Me), 61.9 (OCH2), 62.8 (OCH2), 109.8 (CH), 110.0 (CH),
124.5 (CH), 125.0 (CH), 130.6 (CH), 132.2 (C), 133.7 (C), 147.9 (C), 160.8 (C O), 161.9 (C O), 179.5 (C S). MS
(EI, 70 eV): m/z (%) 321 (M+, 11), 276 (10), 248 (100), 220 (75), 176 (13), 150 (6), 76 (7). Anal. Calcd. for
C15H15NO5S (321.34): C, 56.07%; H, 4.70%; N, 4.36%. Found: C, 56.11%; H, 4.75%; N, 4.40%.
Di-tert-butyl 2-(2-thioxobenzo[d]oxazol-3(2H)-yl) f umarate (3c): Yellow powder, yield: 0.31 g (82%), mp: 97–
99 8C. IR (KBr): 1737 (C O), 1728 (C O) cmÀ1. 1H NMR (CDCl3): d 1.08 (s, 9 H, Me3C), 1.25 (s, 9 H, Me3C), 6.84–
6.87 (m, 1 H, CH), 7.25–7.28 (m, 2 H, 2 CH), 7.37 (s, 1 H, CH), 7.38–7.40 (m, 1 H, CH). 13C NMR (CDCl3): d 27.4
(Me3C), 28.3 (Me3C), 79.7 (OCMe3), 80.1 (OCMe3), 109.4 (CH), 110.9 (CH), 124.1 (CH), 125.1 (CH), 130.4 (CH),
131.7 (C), 134.0 (C), 147.7 (C), 161.2 (C O), 162.5 (C O), 179.9 (C S). MS (EI, 70 eV): m/z (%) 377 (M+, 3), 305
(11), 277 (100), 249 (55), 205 (30), 150 (9), 76 (13). Anal. Calcd. for C19H23NO5S (377.45): C, 60.46%; H, 6.14%; N,
3.71%. Found: C, 60.40%; H, 6.20%; N, 3.74%.
Dimethyl 2-(2-thioxobenzo[d]thiazol-3(2H)-yl) f umarate (3d): Pale yellow crystals, yield: 0.27 g (87%), mp: 124–
126 8C. IR (KBr): 1731 (C O), 1727 (C O) cmÀ1. 1H NMR (CDCl3): d 3.60 (s, 3 H, MeO), 3.84 (s, 3 H, MeO), 6.95
(s, 1 H, CH), 7.37 (t, 1 H, 3J = 7.3, CH), 7.47 (t, 1 H, 3J = 7.4, CH), 7.81 (d, 1 H, 3J = 8.0, CH), 7.93 (d, 1 H, 3J = 8.1,
CH). 13C NMR (CDCl3): d 52.3 (MeO), 53.4 (MeO), 121.0 (CH), 122.4 (CH), 125.2 (CH), 127.0 (C), 130.7 (C), 136.2
(CH), 141.6 (C), 153.0 (CH), 164.2 (C O), 164.8 (C O), 179.1 (C S). MS (EI, 70 eV): m/z (%) 309 (M+, 14), 278
(10), 250 (100), 222 (75), 178 (10), 166 (6), 76 (9). Anal. Calcd. for C13H11NO4S2 (309.35): C, 50.47%; H, 3.58%; N,
4.53%. Found: C, 50.49%; H, 3.60%; N, 4.58%.
Di-tert-butyl 2-(2-thioxobenzo[d]thiazol-3(2H)-yl) f umarate (3e): Pale yellow powder, yield: 0.32 g (81%), mp:
117-119 8C. IR (KBr): 1733 (C O), 1726 (C O) cmÀ1. 1H NMR (CDCl3): d 1.1 (s, 9 H, Me3C), 1.30 (s, 9 H, Me3C),
3
3
3
7.0 (s, 1 H, CH), 7.35 (t, 1 H, J = 7.2, CH), 7.44 (t, 1 H, J = 7.4, CH), 7.84 (d, 1 H, J = 8.1, CH), 7.92 (d, 1 H,
3J = 8.3, CH), 13C NMR (CDCl3): d 27.4 (Me3C), 28.3 (Me3C), 79.7 (OCMe3), 80.1 (OCMe3), 121.2 (CH), 122.1
(CH), 125.3 (CH), 127.0 (C), 130.5 (C), 136.4 (CH), 141.3 (C), 153.2 (CH), 162.1 (C O), 164.6 (C O), 178.9 (C S).
MS (EI, 70 eV): m/z (%) 393 (M+, 6), 320 (10), 292 (100), 264 (45), 220 (10), 166 (8), 76 (10). Anal. Calcd. for
C19H23NO4S2 (393.51): C, 57.99%; H, 5.89%; N, 3.56%. Found: C, 58.22%; H, 5.95%; N, 3.64%.
Methyl (Z)-3-(benzo[d]oxazol-2-ylthio)acrylate (10a): White powder, yield: 0.10 g (44%), mp: 122–124 8C. IR
(KBr): 1738 (C O) cmÀ1. 1H NMR (CDCl3): d 3.83 (s, 3 H, Me), 6.23 (d, 1 H, 3J = 9.9, CH), 7.34–7.36 (m, 2 H, 2
CH), 7.51–7.53 (m, 1 H, CH), 7.68–7.69 (m, 1 H, CH), 8.23 (d, 1 H, 3J = 9.9, CH). 13C NMR (CDCl3): d 52.0 (Me),
110.4 (CH), 119.3 (CH), 120.9 (CH), 124.9 (CH), 125.0 (CH), 139.7 (CH), 151.9 (C), 152.0 (C), 162.7 (C N), 166.8
(C O). MS (EI, 70 eV): m/z (%) 235 (M+, 8), 204 (12), 176 (100), 150 (10), 76 (6). Anal. Calcd. for C11H9NO3S
(235.25): C, 56.16%; H, 3.86%; N, 5.95%. Found: C, 56.20%; H, 3.90%; N, 5.99%.
Methyl (E)-3-(benzo[d]oxazol-2-ylthio)acrylate (11a): White powder, yield: 0.12 g (56%), mp: 120–122 8C. IR
(KBr): 1741 (C O) cmÀ1. 1H NMR (CDCl3): d 3.81 (s, 3 H, Me), 6.32 (d, 1 H, 3J = 15.8, CH), 7.31–7.33 (m, 2 H, 2
CH), 7.50–7.51 (m, 1 H, CH), 7.65–7.67 (m, 1 H, CH), 8.30 (d, 1 H, 3J = 15.8, CH). 13C NMR (CDCl3): d 51.9 (Me),
110.3 (CH), 116.6 (CH), 119.0 (CH), 124.6 (CH), 124.7 (CH), 137.6 (CH), 141.6 (C), 151.2 (C), 159.3 (C N), 164.6
(C O). MS (EI, 70 eV): m/z (%) 235 (M+, 8), 204 (12), 176 (100), 150 (10), 76 (6). Anal. Calcd. for C11H9NO3S
(235.25): C, 56.16%; H, 3.86%; N, 5.95%. Found: C, 56.20%; H, 3.90%; N, 5.99%.
Ethyl 4-oxo-4H-[1,3]thiazino[3,2-a]benzimidazole-2-carboxylate (12b): Yellow powder, yield: 0.25 g (91%), mp:
1
3
161–163 8C. IR: 1692 (C O) cmÀ1. H NMR (500 MHz, CDCl3): d 1.38 (t, 3H, J = 6.9 Hz, Me), 4.37 (q, 2H,
3
3J = 7.1 Hz, OCH2), 7.19–7.20 (m, 1H, CH), 7.26–7.38 (m, 2H, 2 CH), 7.65 (d, 1H, J = 7.8 Hz, CH), 7.93 (d, 1H,
3J = 7.6 Hz, CH). 13C NMR (75 MHz, CDCl3): d 13.6 (Me), 61.8 (OCH2), 112.3 (CH), 119.5 (CH), 121.6 (CH), 124.3